Click here for link to article * Settlement resolves probe into drug marketing practices * Novo Nordisk does not admit wrongdoing in settlement * Company to enter corporate integrity agreement NEW YORK, June 10 (Reuters) – Danish drugmaker Novo Nordisk (NOVOb.CO) will pay $25 million to settle a lawsuit over the alleged improper marketing of […]
Direct link to article By Margaret Jackson The Denver Post Posted: 06/06/2011 01:00:00 AM MDT Updated: 06/06/2011 09:39:32 AM MDT Research assistant Patti Estes with Taiga Biotechnologies prepares stem cells for an experiment at the Anschutz Medical Campus in Aurora last week. Taiga estimates that it could create new adult blood cells for trials on humans […]
Direct link to article By Frederik Joelving NEW YORK | Mon Jun 6, 2011 5:39pm EDT (Reuters Health) – Drugs for rare cancers are allowed to hit the U.S. market based on low-quality clinical tests that raise concerns about both safety and efficacy, researchers said Monday. Known as orphan drugs, such medications are used to […]
New York Times article link By CARL ZIMMER Published: May 30, 2011 Hepatitis C is, in some ways, a high-profile disease. Worldwide, an estimated 200 million people are infected with the virus. Some of them will suffer cirrhosis, liver cancer and even death. Celebrities like Steven Tyler of Aerosmith and “American Idol” have spoken publicly […]
FDA NEWS RELEASE For Immediate Release: May 20, 2011 Media Inquiries: Erica Jefferson, 301-796-4988, firstname.lastname@example.org Consumer Inquiries: 888-INFO-FDA Click here for a link to the full press release. FDA approves new HIV treatment The U.S. Food and Drug Administration today approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection […]
GTC Biotherapeutics, Inc., a LFB Group Company, Granted Protection until 2027 on Broad Transgenic Protein Production Patent, and is Also Granted New Patent on Recombinant Anti-Thrombin Produced Transgenically
Click here for full Business Wire article FRAMINGHAM, Mass.–(BUSINESS WIRE)–GTC Biotherapeutics, Inc. (GTC) (a wholly-owned subsidiary of LFB Biotechnologies S.A.S., Les Ulis, France), announced today that the United States Patent and Trademark Office (USPTO) granted (to GTC) a patent covering DNA constructs for the production of any therapeutic protein in the milk of any transgenic […]
Click here for New York Times article. By ANDREW POLLACK Published: May 13, 2011 The Food and Drug Administration approved on Friday the first of a new generation of hepatitis C drugs that promises to increase the cure rate while shortening the time required for treatment. The new drug, Victrelis from Merck, effectively cured more […]
Link to Article Embryonic tools will boost research into inherited diseases Kim Kozlowski / The Detroit News Ann Arbor— A collaboration between the University of Michigan and a renowned Detroit doctor has led to new embryonic stem cell lines that will allow researchers to study how certain diseases form and progress, officials will announce today. […]
Contact: Customer Service 262-538-2900 FOR IMMEDIATE RELEASE — March 15, 2011 —Hartland, Wisconsin, H&P industries, Inc., a manufacturer of over-the-counter products has initiated a voluntary product recall of ALL LOTS of POVIDINE PREP PADS manufactured by H&P Industries, Inc. but which are private labeled for many accounts. This recall has been initiated due to results of the […]
Pfizer Inc. And Progenics Alert Physicians And Patients To Information Related To Triad Group Alcohol Prep Products Included In U.S. RELISTOR Kit Packaging Wed, 26 Jan 2011 10:53:00 -0600 NEW YORK, N.Y. and TARRYTOWN, N.Y.
Pfizer Inc. and Progenics Pharmaceuticals, Inc. have learned of a United States market recall of alcohol prep pads and swabs manufactured by the Triad Group. In the interest of patient safety, Pfizer and Progenics are alerting U.S. patients and physicians to Triad’s recall.
Assisting and Advocating for the Bleeding Disorders Community